Artificial Intelligence in IVD Market Growth, Size, Trends Analysis - By Application, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Artificial Intelligence in IVD Market Introduction and Overview

According to SPER market research, 'Global Artificial Intelligence in IVD Market Size- By Application, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Artificial Intelligence in IVD Market is predicted to reach 2.62 billion by 2033 with a CAGR of 22.6%.

The application of machine learning and computational algorithms to the analysis and interpretation of diagnostic data is known as artificial intelligence (AI) in in-vitro diagnostics (IVD). This is done to enhance clinical decision-making, accuracy, and efficiency in laboratory testing and medical diagnostics. Diabetes, heart disease, and cancer are among the chronic illnesses that are becoming more prevalent globally. AI is being used more and more to enhance the effectiveness, accuracy, and customized treatment options for a range of illnesses.

The Covid-19 epidemic has highlighted the value of artificial intelligence (AI) in in vitro diagnostics, particularly in domains such as medical imaging and clinical decision support. AI technology have helped in the identification and management of Covid-19 patients, allowing for the quick analysis of chest X-rays and CT scans to detect lung abnormalities. AI has also aided the creation of predictive models and risk assessment tools to help healthcare providers manage the epidemic. The epidemic has expedited the use of AI in diagnostics, fostering innovation and collaboration in the field.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Application, By Technology, By End User

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Danaher Corporation (Beckman Coulter), Sysmex Corporation, BioMerieux, Shenzhen Mindray Bio-Medical Electronics Co, Cardinal Health, PerkinElmer.

Artificial Intelligence in IVD Market Segmentation:

By Application: Based on the Application, Global Artificial Intelligence in IVD Market is segmented as; Oncology, Infectious Disease, Cardiology, Other Applications.

By Technology: Based on the Technology, Global Artificial Intelligence in IVD Market is segmented as; Machine Learning, Deep Learning, Other Technologies.

By End User: Based on the End User, Global Artificial Intelligence in IVD Market is segmented as; Hospitals and Clinics, Diagnostic Laboratories, Other End Users.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Product Code: MEDE2501

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Artificial Intelligence in IVD Market.

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Artificial Intelligence in IVD Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Artificial Intelligence in IVD Market

7. Global Artificial Intelligence in IVD Market, By Application (USD Million) 2020-2033

7.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Application, 2020-2026
7.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Application, 2027-2033
7.3. Oncology
7.4. Infectious Disease
7.5. Cardiology
7.6. Other Applications

8. Global Artificial Intelligence in IVD Market, By Technology (USD Million) 2020-2033

8.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Technology, 2020-2026
8.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Technology, 2027-2033
8.3. Machine Learning
8.4. Deep Learning
8.5. Other Technologies

9. Global Artificial Intelligence in IVD Market, By End User (USD Million) 2020-2033

9.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By End User, 2020-2026
9.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By End User, 2027-2033
9.3. Hospitals and Clinics
9.4. Diagnostic Laboratories
9.5. Other End Users

10. Global Artificial Intelligence in IVD Market Forecast, 2020-2033 (USD Million)

10.1. Global Artificial Intelligence in IVD Market Size and Market Share

11. Global Artificial Intelligence in IVD Market, By Region, 2020-2033 (USD Million)

11.1. Global Artificial Intelligence in IVD Market Size and Market Share By Region (2020-2026)
11.2. Global Artificial Intelligence in IVD Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
- 11.3.1. Australia
- 11.3.2. China
- 11.3.3. India
- 11.3.4. Japan
- 11.3.5. South Korea
- 11.3.6. Rest of Asia-Pacific
11.4. Europe
- 11.4.1. France
- 11.4.2. Germany
- 11.4.3. Italy
- 11.4.4. Spain
- 11.4.5. United Kingdom
- 11.4.6. Rest of Europe
11.5. Middle East and Africa
- 11.5.1. Kingdom of Saudi Arabia
- 11.5.2. United Arab Emirates
- 11.5.3. Qatar
- 11.5.4. South Africa
- 11.5.5. Egypt
- 11.5.6. Morocco
- 11.5.7. Nigeria
- 11.5.8. Rest of Middle-East and Africa
11.6. North America
- 11.6.1. Canada
- 11.6.2. Mexico
- 11.6.3. United States
11.7. Latin America
- 11.7.1. Argentina
- 11.7.2. Brazil
- 11.7.3. Rest of Latin America

12. Company Profile

12.1. Abbott
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. F. Hoffmann-La Roche Ltd
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Siemens Healthineers AG
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Thermo Fisher Scientific Inc
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Danaher Corporation
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Sysmex Corporation
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. BioMerieux
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Shenzhen Mindray Bio-Medical Electronics Co
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Cardinal Health
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. PerkinElmer
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others